NVAX trade ideas
Symmetrical TriangleSymmetrical Trangles can break either way. A period of consolidation and is considered a neutral pattern. Triangles can also be continuation patterns. NVAX has broken the upper trendline
Price cam up to form this so touch one is on the upper trendline. The 5th touch can be the charm but not always. This one broke the upper trendline on the 5th touch. Price can be dwelling in a triangle for quite some time. When it pushes to the apex, price is "squeezed" snd as a rule it will finally break one way othe other.
No recommendation
$NVAX Gartley Pattern Watching price reversal zone on $NVAX, we took this long from 206 to 262, lets see if we get a reentry chance, prz zone due to 3 triggers per Gartley Pattern rules
Top U.S. trade negotiator discusses vaccine ramp-up with NovavaxGovernments around the world are desperate to ramp up inoculations in fear of a second or third wave of Corona coming through and potentially decimating their economies if they are forced to shut down again.
Novavax going through a Bolly Breakout with significant volume. Will it be another bull run?
NVAX two inside days in a row last weekNVAX two inside days in a row last week. Watching above 217.25 for an entry. Earnings on May 5.
NVAX Rebound WaveNVAX is looking to complete its correction wave pattern. Its holding above its moving averages at the top of the flagging range. It is close to the apex of the range looking to breakout. Looking this to run to 250 area.
Set alert and wait. Nvax pennant Forming a pennant on daily chart. Johnson &Johnson's misfortune still wasn't enough to push through. Channel resistance intersects with fib resistance at 204.
Public info says vaccine approval expected for UK and US use this quarter.
Entry 204 or pennant break out
targets (Green lines) are fib resistance
$NVAX getting ready for break out Price has been respecting the daily uptrend on this pennant pattern formed on the daily time frame. The pattern its formed suggest a break out will likely follow. With the president trying to get everyone vaccinated as soon as possible im bullish on the catalyst. The daily RSI is in a neutral position, and the stochastic looks to be shifting towards the upside. On the 4hr and 1 hr the stochastic are showing bullish potential with no crosses in the moving averages. I charted this on the daily so ill be looking to buy at least 30 days out. Not much more to say here other than buy the dip.
lmk what y'all think about the TA
$NVAX Novavax Reverses off Major Support
After a 20% drop this morning the stock staged quiet a nice recovery after hitting multiple supports=
- The Fibonacci Golden pocket
- The ascending trendline
- The 100MA.
resulting in a 10% reversal trade.
Lets see what Fridays brings and the possibility for a bounce in the Nasdaq and Biotech sector.
ABC BullishNVAX pulled back, found a large gap, filled it and appears to want to move upward.
Possible stop below C or last pivot low
Possible Targets 2 432.5 to 500
Not a recommendation.
Can be volatile
ABC BullishNVAX pulled back, found a large gap, filled it and appears to want to move upward.
Possible stop below C or last pivot low
Possible Targets 2 432.5 to 500
Not a recommendation.
Can be volatile
NVAX Round upNVAX gapped down today right into its moving average support. I believe its going to finish its rounding pattern and exceed the highs from yesterday. The 50 sma is at support as well at the 201 mark. I was able to enter at 214, but couldn't post this idea right away. Target is at the top of rounding formation at 245
Nvax ReversalBroke above 217.88 (yellow line) heavy resistance premarket.
Good news has been coming out of this company as far as vaccine trials.
American FDA approval could come around may and with that AstraZeneca nightmare in Germany, early Europe approval could be in play.
stop loss at 217
Targets are Fibonacci (Greenlines)
Novavax on to new highsNVAX could not even break and retest the old Resistance from August, it also formed a nice setup, where the break was also a break of the downtrendline at the same time.
Todays Session retested both, now forming a double support, which could allow us some decent gains...
Trading Novavax after BreakoutNVAX jumped roughly 20% overnight after announcing 96.4% efficacy against the disease caused by the original COVID-19 strain. This single move caused the shares to break out from the downside channel and crack through the 50-day and 20-day moving averages. With this important resistance zone left behind, the shares are poised to open just above the yearly Fibonacci R2 and monthly S1 levels ($216 and $213; RY2 and SM1 lines on the chart).
The question is whether the bulls can push the stock even higher today. Personally, I do not rule out that such a powerful upside gap - amid broader market concerns - could trigger some profit taking. Therefore, I will be watching to see if the stock can hold the RY2 / SM1 zone. If this happens, we can see NVAX approaching the $250 zone followed by the monthly pivot level ($258, PM) near-term.
On the downside , a break below RY2 / SM1 will put the 20- and 50-day moving averages to the test. An even more bearish scenario involves retesting recent diagonal resistance and potential gap filling at $188. This zone, however, should serve as very strong support, where we will definitely see buybacks.
